ADAMTS13 and thrombotic thrombocytopenic purpura: The ADAMTS13 results confirmed the diagnosis of acquired TTP and the patient was started on pulse steroids (IV 1g) and plasma exchange therapy (40ml\kg), which was planned to continue until improvement in the platelet count to more than 150,000 for two consecutive occasions, along with improvement in the LDH and renal function.